FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

Minirin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 19 USDMF, 13 CEP/COS, 2 JDMF, 3 EU WC, 10 KDMF, 30 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

FINISHED DOSAGE FORMULATIONS

299 FDF Dossiers, 53 FDA Orange Book, 198 Europe, 12 Canada, 12 Australia, 8 South Africa, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;NASAL - 0.01%, SPRAY, METERED;NASAL - 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.004MG/ML, TABLET;ORAL - 0.1MG, TABLET;ORAL - 0.2MG, SPRAY, METERED;NASAL - 0.00083MG/SPRAY, SPRAY, METERED;NASAL - 0.00166MG/SPRAY, SPRAY, METERED;NASAL - 0.15MG/SPRAY, SPRAY, METERED;NASAL - 0.01MG/SPRAY, TABLET;SUBLINGUAL - 0.0277MG, TABLET;SUBLINGUAL - 0.0553MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 15 BASF, 1 CD Formulation, 2 DFE Pharma, 1 DKSH, 1 Finar, 7 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 12 Kerry, 10 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 7 Roquette, 5 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Sigachi Industries, 1 Silverline Chemicals, 1 Symrise, 2 Ulanqab Kema New Material, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 19 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Granulation, 17 Solubilizers, 13 Lubricants & Glidants, 13 Parenteral, 10 Thickeners and Stabilizers, 9 Chewable & Orodispersible Aids, 7 Controlled & Modified Release, 7 Emulsifying Agents, 7 Co-Processed Excipients, 5 Topical, 5 Surfactant & Foaming Agents, 5 Taste Masking, 3 Coating Systems & Additives, 3 Film Formers & Plasticizers, 2 API Stability Enhancers

DIGITAL CONTENT

31 News #PharmaBuzz

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 24 Regulatory FDF Prices

MARKET PLACE

9 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 14 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/01/2026	Anygen	South Korea	HLB Pep Co., Ltd.	20180905-209-J-198	Desmopressin acetate	2018-09-05	HLB Pep Co., Ltd.	South Korea	Test Production Building 2 (3-story building) within the Jeollanam-do Nanobio Center, 123 Nanosandan-ro, Nammyeon, Jangseong-gun, Jeollanam-do
29/01/2026	Hybio Pharmaceutical	China	Hanyoung Farm Co., Ltd.	20181018-209-J-84(2)	Desmopressin acetate	2021-07-11	Hybio Pharmaceutical Co., Ltd.	China	37 Keji C. St. 2nd, Shenzhen Hi-tech Industrial Park, Guangdong, China

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Minirin

Minirin

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers

19 USDMF

13 CEP/COS

2 JDMF

3 EU WC

10 KDMF

30 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

FINISHED DOSAGE FORMULATIONS

299 FDF Dossiers

53 FDA Orange Book

198 Europe

12 Canada

12 Australia

8 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;NASAL - 0.01%

SPRAY, METERED;NASAL - 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.004MG/ML

TABLET;ORAL - 0.1MG

TABLET;ORAL - 0.2MG

SPRAY, METERED;NASAL - 0.00083MG/SPRAY

SPRAY, METERED;NASAL - 0.00166MG/SPRAY

SPRAY, METERED;NASAL - 0.15MG/SPRAY

SPRAY, METERED;NASAL - 0.01MG/SPRAY

TABLET;SUBLINGUAL - 0.0277MG

TABLET;SUBLINGUAL - 0.0553MG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

2 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

3 Kirsch Pharma

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

15 BASF

1 CD Formulation

2 DFE Pharma

1 DKSH

1 Finar

7 Gangwal Chemicals

2 Ingredion Pharma Solutions

12 Kerry

10 Microlex e.U

1 Nitika Pharmaceutical Specialities

2 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

1 Prachin Chemical

7 Roquette

5 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

3 Sigachi Industries

1 Silverline Chemicals

1 Symrise

2 Ulanqab Kema New Material

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders

19 Direct Compression

19 Disintegrants & Superdisintegrants

17 Granulation

17 Solubilizers

13 Lubricants & Glidants

13 Parenteral

10 Thickeners and Stabilizers

SPRAY, METERED;NASAL - 0.01MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons